Stay updated with breaking news from Nasdaq Ontx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance Onconova Therapeutics has a 1-year low of $0.55 and a 1-year high of $1.45. The company […]
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Onconova Therapeutics Stock Performance Onconova Therapeutics has a fifty-two week low of $0.55 and a fifty-two week high of $1.45. The stock has a […]
StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The firm has a 50 day simple moving average of $0.82 and a 200 day simple moving average of $0.74. […]
Stock analysts at StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The stock has a market cap of $20.90 million, a PE ratio of -1.09 and a […]
Analysts at StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research note issued on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Trading Down 1.0 % Shares of ONTX opened at $1.00 on Friday. Onconova Therapeutics has a twelve month low of […]